| scholarly article | Q13442814 |
| P50 | author | John R. Ingram | Q46750825 |
| P2093 | author name string | John Rhodes | |
| Gareth A O Thomas | |||
| Brian K Evans | |||
| P2860 | cites work | A meta-analysis of the role of smoking in inflammatory bowel disease | Q28262131 |
| Risk of ulcerative colitis among former and current cigarette smokers | Q34191807 | ||
| An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics | Q36053862 | ||
| Nicotine enemas for active ulcerative colitis--a pilot study | Q40879021 | ||
| A dose-ranging pharmacokinetic study of nicotine tartrate following single-dose delayed-release oral and intravenous administration | Q42546830 | ||
| Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: a pilot study | Q42547552 | ||
| Acquired microvascular dysfunction in inflammatory bowel disease: Loss of nitric oxide-mediated vasodilation | Q44507322 | ||
| Nicotine enemas for treatment of ulcerative colitis: a study of the pharmacokinetics and adverse events associated with three doses of nicotine. | Q45103011 | ||
| Crohn's disease patients who quit smoking have a reduced risk of reoperation for recurrence. | Q45941852 | ||
| Transdermal nicotine for active ulcerative colitis | Q48848039 | ||
| Cigarette Smoking and Ulcerative Colitis | Q57945835 | ||
| P433 | issue | 12 | |
| P921 | main subject | inflammatory bowel diseases | Q917447 |
| P304 | page(s) | 1092-1096 | |
| P577 | publication date | 2005-12-01 | |
| P1433 | published in | Inflammatory Bowel Diseases | Q15749161 |
| P1476 | title | Preliminary observations of oral nicotine therapy for inflammatory bowel disease: an open-label phase I-II study of tolerance | |
| P478 | volume | 11 |
| Q37088221 | Activation of the cholinergic antiinflammatory pathway reduces ricin-induced mortality and organ failure in mice |
| Q41334331 | Burn-induced organ dysfunction: vagus nerve stimulation improves cardiac function |
| Q33866877 | Exploitation of the nicotinic anti-inflammatory pathway for the treatment of epithelial inflammatory diseases |
| Q36989832 | Genetic variability in CYP2A6 and the pharmacokinetics of nicotine |
| Q36700662 | Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis. |
| Q30459624 | Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia |
| Q36869518 | Nicotine enemas for active Crohn's colitis: an open pilot study |
| Q51791065 | The activity of the immunoregulatory enzyme indoleamine 2,3-dioxygenase is decreased in smokers. |
| Q36613876 | Update in the treatment of paediatric ulcerative colitis |
| Q36636016 | What is the origin of ulcerative colitis? Still more questions than answers |
Search more.